Quanterix logo

QuanterixNASDAQ: QTRX

Profile

Sector:

Healthcare

Country:

United States

IPO:

07 December 2017

Next earnings report:

27 February 2025

Last dividends:

N/A

Next dividends:

N/A
$421.40 M
-75%vs. 3y high
63%vs. sector
-vs. 3y high
-vs. sector
-66%vs. 3y high
44%vs. sector
-80%vs. 3y high
51%vs. sector

Price

regular market | 4 min ago
$10.98-$0.04(-0.36%)

Dividend

No data over the past 3 years
$34.13 M$34.00 M
$34.13 M-$9.47 M

Analysts recommendations

Institutional Ownership

QTRX Latest News

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Quanterix Corporation For Securities Fraud
accesswire.com21 November 2024 Sentiment: -

LOS ANGELES, CA / ACCESSWIRE / November 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Quanterix Corporation for potential violations of securities laws
prnewswire.com21 November 2024 Sentiment: NEGATIVE

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION  NEW YORK , Nov. 21, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that is investigating potential claims against Quanterix Corporation ("Quanterix" or the "Company") (NASDAQ:QTRX) on behalf of Quanterix stockholders. The investigation concerns whether Quanterix and certain of its officers and/or directors have engaged in securities fraud.

Wolf Haldenstein Adler Freeman & Herz LLP Announces that it is Investigating Quanterix Corporation for Potential Violations of Securities Laws
accesswire.com20 November 2024 Sentiment: NEGATIVE

NEW YORK CITY, NY / ACCESSWIRE / November 20, 2024 / PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that is investigating potential claims against Quanterix Corporation ("Quanterix" or the "Company")( NASDAQ:QTRX) on behalf of Quanterix stockholders. The investigation concerns whether Quanterix and certain of its officers and/or directors have engaged in securities fraud.

Quanterix Corporation Investigated Regarding Potential Securities Law Violations - Contact Levi & Korsinsky for Details - QTRX
accesswire.com19 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 19, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Quanterix Corporation ("Quanterix Corporation") (NASDAQ:QTRX) concerning possible violations of federal securities laws. After the market closed, on November 12, 2024, Quanterix announced that it had "identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021," which had affected the valuation of its inventory.

Quanterix Corporation Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - QTRX
accesswire.com18 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 18, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Quanterix Corporation ("Quanterix Corporation") (NASDAQ:QTRX) concerning possible violations of federal securities laws. After the market closed, on November 12, 2024, Quanterix announced that it had "identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021," which had affected the valuation of its inventory.

The Schall Law Firm Encourages Stockholder Participation In An Inquiry Into Quanterix Corporation's Securities Law Violations
accesswire.com17 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Quanterix Corporation (QTRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
accesswire.com17 November 2024 Sentiment: NEGATIVE

NEW YORK CITY, NY / ACCESSWIRE / November 17, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX). Investors who purchased Quanterix securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/QTRX.

Quanterix Corporation Is Being Looked Into For Fraud And Affected Investors Should Reach Out To The Schall Law Firm
accesswire.com16 November 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / November 16, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Quanterix Corporation ("Quanterix" or "the Company") (NASDAQ:QTRX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Qaunterix Corporation (NASDAQ: QTRX) Investors with Losses to Contact the Firm
globenewswire.com15 November 2024 Sentiment: NEGATIVE

SAN FRANCISCO, Nov. 15, 2024 (GLOBE NEWSWIRE) -- Girard Sharp, LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of Qaunterix Corporation (NASDAQ: QTRX) investors.

Levi & Korsinsky Reminds Shareholders of an Investigation into Quanterix Corporation (QTRX) Regarding Potential Securities Fraud Allegations
accesswire.com15 November 2024 Sentiment: NEGATIVE

NEW YORK, NY / ACCESSWIRE / November 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Quanterix Corporation ("Quanterix Corporation") (NASDAQ:QTRX) concerning possible violations of federal securities laws. After the market closed, on November 12, 2024, Quanterix announced that it had "identified an error regarding the capitalization of labor and overhead costs applied to prior periods, dating back to at least 2021," which had affected the valuation of its inventory.

  • 1(current)
  • 2
  • 3

What type of business is Quanterix?

Quanterix Corporation develops an ultra-sensitive platform for digital immunoassay and tools for medical-biological research and diagnostics. The company offers a single molecule platform (Simoa) that uses single molecule measurements to detect protein biomarkers. The company also focuses on implementing and developing new treatment and diagnostic methods, making medical services easier for early detection, monitoring, prognosis, and ultimately disease prevention. Simoa specializes in research and clinical trials and significantly advances the enzyme-linked immunosorbent assay (ELISA) technology, providing unprecedented sensitivity in protein detection. Quanterix Corporation was founded in 2007, with its headquarters located in Billerica, Massachusetts.

What sector is Quanterix in?

Quanterix is in the Healthcare sector

What industry is Quanterix in?

Quanterix is in the Medical Devices industry

What country is Quanterix from?

Quanterix is headquartered in United States

When did Quanterix go public?

Quanterix initial public offering (IPO) was on 07 December 2017

What is Quanterix website?

https://www.quanterix.com

Is Quanterix in the S&P 500?

No, Quanterix is not included in the S&P 500 index

Is Quanterix in the NASDAQ 100?

No, Quanterix is not included in the NASDAQ 100 index

Is Quanterix in the Dow Jones?

No, Quanterix is not included in the Dow Jones index

When was Quanterix the previous earnings report?

No data

When does Quanterix earnings report?

The next expected earnings date for Quanterix is 27 February 2025